Month: November 2021

Aptevo Therapeutics Reports First Complete Remission, Providing Clinical Update for Its Phase 1b Multi Center, Multi Cohort Expansion Trial in the Treatment of Acute Myeloid Leukemia

SEATTLE, WA / ACCESSWIRE / November 23, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology...

Limitless Venture Group, Inc. Posts Record Revenue for The Third Quarter 2021, The Sixth Consecutive Record Revenue Quarter and has Already More than Doubled 2020 Annual Revenues, Equaling $.0732/Share in Revenues

error: Content is protected !!